Claritev Corp
No enriched coverage for $CTEV in the last 7 days.
Dalton Travis (Pres., CEO & Executive Chair) purchased 6,450 indirectly-held shares of Claritev Corp (CTEV) at an average of $38.71 ($38.48–$38.81, $0.25M total) across 2 trades over 2026-08-27 to 2026-08-28.
Misencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares of Claritev Corp (CTEV) at $40.07 ($0.35M total) on 2026-08-14.
Mintz William B. (SVP, Chief Strategy Officer) sold 8,431 shares of Claritev Corp (CTEV) at $34.24 ($0.29M total) on 2026-08-10.
Recent CTEV coverage spans insider activity, earnings and financial news.
In the last 30 days, CTEV insiders filed 4 SEC Form 4 transactions — 2 purchases ($250K) and 2 sales ($643K). The most active reporter was Dalton Travis, Pres., CEO & Executive Chair, with 2 filings.
Insider purchase signals confidence but size is modest.
This is a routine insider sale under a Form 4, with no stated link to company fundamentals or new guidance.
This is a routine Form 4 insider sale with no 10b5-1 plan stated, but it does not by itself signal a fundamental change.
Analyst target hike and platform thesis may support near-term sentiment, but the article also flags unprofitability and notes valuation concerns.
Raised FY outlook and bookings momentum suggest improving visibility into revenue conversion, with AI and No Surprises Act demand as key drivers.
alphai scores every news story that mentions CTEV with an AI model for sentiment and relevance, and aggregates insider trades from Claritev Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Dalton Travis (Pres., CEO & Executive Chair) purchased 6,450 indirectly-held shares of Claritev Corp (CTEV) at an average of $38.71 ($38.48–$38.81, $0.25M total) across 2 trades over 2026-08-27 to 2026-08-28.
1 min readMisencik Tiffani (SVP, Chief Growth Officer) sold 8,850 shares of Claritev Corp (CTEV) at $40.07 ($0.35M total) on 2026-08-14.
1 min readMintz William B. (SVP, Chief Strategy Officer) sold 8,431 shares of Claritev Corp (CTEV) at $34.24 ($0.29M total) on 2026-08-10.
1 min readPiper Sandler raised its price target for Claritev (NYSE:CTEV) to $73 from $61 and kept an Overweight rating. The stock was about $35.39. The firm cited platform and operating infrastructure improvements, a 1.4 million provider network, and expects profitability in fiscal 2026 with EPS forecast of $5.83.
4 min readClaritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.
5 min readClaritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202
6 min readClaritev (NYSE: CTEV) said it will adopt CodeTogether’s AITrax to measure adoption, cost, quality, and value from its AI-assisted software development efforts. Claritev previously used CodeTogether’s engineering intelligence platform starting in 2022, reporting a 59% increase in issue throughput and a 48% increase in active development time. The companies aim to track AI ROI and spend via IDE and agent telemetry.
3 min readCarol Nutter (SVP, Chief People Officer) purchased 875 shares of Claritev Corp (CTEV) at $28.41 on 2026-06-09.
1 min readClaritev ( NYSE:CTEV ) , a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million ( GAAP ) in Q2 2025, which exceeded analyst estimates by $10.2 million ( GAAP ) .
2 min readHOLLYWOOD, Fla., May 06, 2025 ( GLOBE NEWSWIRE ) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan CTEV, a technology and data insights company focused on making healthcare more affordable, transparent ...
3 min read
